A combination capsule, containing 40 mg
Dihydroartemisinin (DHA) and 320
mg Piperaquine phosphate (PQP).
Indications:
Anti-malarial for malaria caused by
P. falciparum and P. vivax.
Evaluating, building, implementing and managing information technology to support work in delivering and managing care
K&K http://www.king-repa.com
Karen hospital -www-karenhospital.org